Every Dollar You Waste on the Wrong Channel Is a Case Your Competitor Signed
Mass tort advertising channels determine case acquisition costs more than any other single variable a plaintiff firm controls. In 2026, the landscape spans paid search, programmatic display, connected TV, social media, lead generation networks, and co-counsel referral pipelines, each with distinct economics, claimant pool reach, and competitive dynamics. Choosing the wrong channel for a given tort burns budget without building a docket. This post breaks down the major channels, their realistic cost benchmarks, and how to allocate budget strategically.
This post lays out the major channels available to plaintiff firms today, the realistic economics behind each one, and how to think about allocating budget when you are running a serious campaign rather than dabbling.
Why Channel Selection Is a Bottom-Line Decision, Not a Marketing Decision
Plaintiff firm owners sometimes treat advertising channel selection as something to hand off to an agency and forget about. That instinct makes sense when you are busy managing litigation, but it costs you. The channel drives the lead quality, the intake burden, the speed to signing, and ultimately the cost basis of every case on your docket. A case signed from a highly targeted Facebook video campaign in a narrow geographic window looks very different on your books than a case purchased through a lead aggregator who sold the same name to six other firms.
Understanding where your cases are actually coming from, and what each channel is producing per dollar, is one of the highest-leverage things a managing partner can do. This is not marketing theory. It is case economics. The litigation timeline on an MDL, the current settlement posture, the size of the eligible claimant pool, the demographics of that pool, and the competitive density of other advertisers all determine which mass tort advertising channels make sense to activate right now versus which ones will burn your budget for marginal return.
The Major Mass Tort Advertising Channels and What Each One Actually Produces
Facebook and Instagram (Meta)
Meta remains the dominant paid channel for mass tort plaintiff acquisition. The targeting depth is unmatched. You can layer age, geography, behavioral signals, and lookalike audiences built from your own signed-case data. For most torts, this is where the largest share of direct-to-consumer advertising dollars go, and for good reason. When a campaign is structured correctly, Facebook delivers a cost per lead in the $30 to $150 range depending on the tort, with signed-case costs ranging from a few hundred dollars on high-volume commodity torts to several thousand on complex, lower-volume litigation.
The downside is that Meta's ad policies around health and legal topics are strict and inconsistently enforced. Campaigns get flagged. Accounts get restricted. Firms that are not set up correctly lose days or weeks of momentum at critical campaign windows. That matters enormously when you are trying to capitalize on a news cycle or a settlement announcement.
Television (Linear and Connected)
TV still works for mass tort lead generation, particularly for torts with broad demographic profiles, older claimant pools, or national footprints. Linear TV has become more affordable as inventory has shifted, and connected TV (CTV) now lets you buy highly targeted streaming placements with performance tracking that was impossible five years ago. The caveat is that TV requires creative quality and media buying expertise that most firms do not have in-house. A poorly produced TV spot in a saturated market is money down a drain. Done well, it can anchor a multi-channel strategy by building the brand awareness that makes your digital ads convert at a higher rate.
Paid Search (Google and Bing)
Search is intent-based. Someone typing a specific tort name or drug name into Google is further along in awareness than someone scrolling through Facebook who happens to match a demographic profile. That intent drives higher conversion rates but also higher costs per click. Competitive mass tort keywords on Google can run $20 to $80 per click or more, and in some torts, the cost per lead through search is prohibitive unless you have a high-volume, well-optimized funnel waiting on the other side. Search works best as part of a broader channel mix, capturing the high-intent traffic that your TV and social campaigns generate awareness for.
Programmatic Display and Native Advertising
Programmatic lets you buy ad impressions across thousands of sites using audience data and behavioral targeting. Native advertising, where paid content blends with editorial format on news and content sites, can generate leads at competitive costs when the creative is strong. Neither channel typically outperforms Facebook or TV as a primary driver, but both are useful for reinforcing campaigns and reaching audiences in environments where Meta's restrictions make direct advertising difficult.
Lead Aggregators and Co-Counsel Networks
Buying leads from aggregators or cases through co-counsel referral networks is technically not advertising, but for many firms it functions as the same budget line. The economics vary wildly. Some aggregators deliver exclusive, well-qualified leads. Many do not. The critical variable is exclusivity and qualification standards. If a lead has been sold to three firms before it reaches you, your conversion rate on that lead drops dramatically and your intake team burns time they should be spending on leads your own campaigns generated. Treat aggregator relationships as a supplement to owned media, not a replacement for it.
The Numbers: What "Good" Actually Looks Like
Benchmarks shift by tort and by competitive environment, so treat these as directional rather than fixed. On Facebook, a well-run campaign for a mid-tier mass tort should produce leads between $50 and $120 each, with a lead-to-sign rate of 15 to 30 percent for a competent intake team, putting your cost per signed case somewhere in the $250 to $600 range. High-value torts like Camp Lejeune or major pharmaceutical litigations have seen signed-case costs run much higher due to competition, sometimes north of $1,500 to $2,500, but the expected case value justifies it.
On Google search, assume two to three times the lead cost of Facebook for comparable volume, offset by higher intent and somewhat better conversion rates. TV campaigns need to be evaluated on a longer attribution window since the response curve plays out over days, not hours.
The firms winning on cost per case are not always spending the most. They are spending on the right mass tort advertising channels at the right time in the litigation cycle, with creative that converts and intake operations that do not bleed leads.
How to Execute: What Separates the Winners
A few things separate firms that get strong returns from firms that do not. First, timing. Advertising into an MDL that is years from resolution ties up capital for a long time. Advertising when a settlement is being announced or when a major news event spikes awareness can cut your lead costs dramatically because the market has done some of the education work for you.
Second, creative. Vague, generic ads perform poorly. Ads that speak specifically to the experience of someone who used a particular product or drug, without being exploitative or crossing bar rules, convert significantly better. Test multiple creative angles. Kill what does not work within the first week. Scale what does.
Third, intake. The best advertising spend in the world fails if your intake team cannot handle call volume, qualifies inconsistently, or takes days to respond to web submissions. Lead response time is one of the most studied variables in legal marketing. Speed to contact matters more than almost any other intake variable once the lead is in the door.
Pitfalls and Compliance: What Trips Firms Up
Bar rules on attorney advertising vary by state, and mass tort campaigns that run nationally need to be reviewed against the rules of every state where you are licensed or where claimants will be located. Disclaimer requirements, claim language, and testimonial rules all have teeth.
TCPA compliance is a real exposure point. If your intake team or vendor is texting or calling leads without proper consent documentation, you are building a litigation liability into your lead gen operation. Get the consent language right before you scale. Similarly, CIPA (California Invasion of Privacy Act) claims against law firm websites have increased. Review your website's tracking setup before running high-volume campaigns.
On the platform side, overly aggressive health or legal claim language in ad copy will get your Meta account flagged. Running campaigns through business manager structures that are not properly set up means a single policy violation can shut down an entire firm's advertising account. That is a disaster during a hot campaign window.
How MTAA Approaches This for Plaintiff Firms
At Mass Tort Ad Agency, we have managed more than $250 million in Facebook ad spend across more than 600 plaintiff law firms and 100-plus mass tort campaigns. Our model is cost-plus: you pay actual ad spend plus a flat 15 percent fee. No markup on media, no hidden margins buried in the numbers. You see exactly what your dollars are doing.
We handle full campaign management across the primary mass tort advertising channels, including Meta, Google, programmatic, and TV buys depending on what the tort and the budget warrant. Our clients get the benefit of cross-campaign data. When we are running the same tort for dozens of firms, we know what creative is working, what lead costs look like in real time, and where the intake bottlenecks tend to form. That institutional knowledge is hard to replicate from a standing start.
We also think about the AI layer. Firms that are using AI tools to accelerate intake qualification, draft demand letters, or analyze claimant data are compressing their timelines and operating costs. If that is an area you want to explore alongside your advertising strategy, the book "A Lawyer's Guide to AI" covers practical applications built specifically for plaintiff firms.
Choosing the Right Mix for Your Firm
There is no universal answer to where to advertise mass torts. The right mix of mass tort advertising channels depends on which litigation you are targeting, where it sits in the MDL timeline, what your intake infrastructure can handle, and what your competitors are already spending. What is consistent is that firms who treat channel selection as a strategic decision tied to case economics, rather than a line item to hand off and forget, sign more cases at lower cost and build dockets with better value profiles. Getting your mass tort advertising channels right is not the whole game, but it is where the game is decided more often than most managing partners realize.
Ready to Build Your Caseload?
Get a free campaign analysis from Mass Tort Ad Agency.
$250M+ in mass tort Facebook ad spend. 600+ law firms served. Transparent cost-plus pricing with no hidden fees.
Schedule a Free Consultation →Frequently Asked Questions: Where to Advertise Mass Torts
Which advertising channels consistently deliver the lowest cost per signed case for mass tort campaigns?
Owned digital channels like targeted Meta and YouTube campaigns typically produce the lowest cost per signed case when the creative is tightly matched to the tort and the geographic window is narrow, because you control the audience and eliminate the markup paid to aggregators. Purchased leads from aggregators carry hidden costs beyond the face price, since the same record is often sold to multiple firms simultaneously, driving up intake labor and reducing conversion rates. Firms that track fully-loaded cost per signed case rather than cost per lead routinely find that direct-to-consumer digital outperforms aggregator volume even when the CPL looks higher on the surface.
How do plaintiff firms evaluate whether enough claimant volume exists to justify building a mass tort advertising campaign around a specific tort?
Before committing significant budget, firms should assess the estimated national exposure population against how many cases have already been filed or signed by competing firms, because a tort with a large theoretical pool can still be effectively exhausted if major consolidators have saturated intake. Third-party diagnostic data, MDL filing velocity, and conversations with litigation funders can all serve as proxies for remaining capturable volume. A shrinking unrepresented pool means rising media costs and longer intake cycles, so channel investment decisions need to account for where a tort sits in its lifecycle.
What advertising channels should plaintiff firms prioritize when launching a new mass tort intake campaign?
Meta platforms remain the highest-volume direct-response channel for most mass torts because of their demographic targeting depth and the ability to deliver video creative that builds enough trust to drive form submissions or inbound calls. Connected TV and programmatic display are increasingly valuable for awareness at scale, particularly in campaigns targeting older demographics who are over-indexed on streaming platforms. Firms using a cost-plus media model, where the agency is compensated on a transparent fee over actual media spend rather than a percentage of spend, tend to allocate budget more efficiently across these channels because the incentive structure removes pressure to inflate volume.
How should a plaintiff firm structure its budget allocation across multiple mass tort advertising channels simultaneously?
Firms running multi-channel campaigns should anchor the majority of direct-response budget to one or two proven channels with measurable cost-per-lead data before testing secondary channels, rather than spreading spend thinly across every available option at once. Assigning unique tracking numbers and intake source codes to each channel is non-negotiable, because without clean attribution data it is impossible to know which channels are producing signed cases versus burning budget. Once a primary channel hits diminishing returns or audience saturation, layering in secondary channels like radio, OTT, or co-registration partners allows the firm to maintain volume without overpaying for an exhausted audience.
What intake and operational factors should plaintiff firms account for before scaling mass tort advertising spend?
Advertising scale is only as effective as the intake infrastructure behind it, and firms that increase spend without sufficient qualified intake staff or a tested CRM workflow will see conversion rates collapse as response times lengthen beyond the window where leads remain engaged. Industry benchmarks suggest that contact rates drop sharply when inbound leads are not reached within the first five minutes, which means staffing and technology decisions directly determine the return on every advertising dollar spent. Before scaling, firms should pressure-test their intake capacity with a controlled spend increase and measure conversion rate stability before committing to a full campaign budget.
